As of Jan 19
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 0.40, with a high estimate of 0.40 and a low estimate of 0.40. The median estimate represents a +15.24% increase from the last price of 0.35.
The current consensus among 1 polled investment analysts is to Hold stock in OHR Pharmaceutical Inc. This rating has held steady since January, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.